Short-term psychotherapeutic treatment in adolescents engaging in non-suicidal self-injury: a randomized controlled trial by unknown
TRIALS
Fischer et al. Trials 2013, 14:294
http://www.trialsjournal.com/content/14/1/294STUDY PROTOCOL Open AccessShort-term psychotherapeutic treatment in
adolescents engaging in non-suicidal self-injury:
a randomized controlled trial
Gloria Fischer, Romuald Brunner, Peter Parzer, Franz Resch and Michael Kaess*Abstract
Background: Worldwide, prevalence rates of adolescent non-suicidal self-injury (NSSI) range between 13 and 45%.
In Germany, lifetime prevalence of NSSI is around 25% in non-clinical samples, and the one-year prevalence for
repetitive NSSI is 4%. NSSI is present in the context of several axis I and II disorders (for example, affective disorders
or borderline personality disorder); however, preliminary evidence suggests that it would be justified to consider
NSSI as its own diagnostic category. Despite the large impact of this behavior, there is still a lack of evidence-based,
specific, and effective manualized treatment approaches for adolescents with NSSI.
Methods/Design: The study is designed as a randomized controlled trial (RCT) to test the effectiveness of a new
cognitive-behavioral treatment manual for self-harming adolescents - the ‘Cutting-Down-Programme’ (CDP). A total
of 80 adolescents aged between 12 and 17 years from a region in Southern Germany who have engaged in
repetitive NSSI (≥5 incidents) in the last 6 months will be randomized into a treatment group (CDP) or a control
group that will receive treatment as usual (TAU). The adolescents will be assessed by means of structured
interviews and questionnaires at three time points (before treatment, directly after treatment and six months after
treatment). Primary outcome criterion is a significant reduction (or remission) in the frequency of NSSI. Secondary
outcome criteria are depressivity as well as general well-being and self-worth. Additionally, comorbid psychiatric
disorders and childhood adversity will be evaluated as predictors of therapeutic outcome.
Discussion: Recently, a pilot study in the United Kingdom showed significant reductions in self-harming behavior,
depressive symptoms and trait anxiety. This is the first RCT to test the effectiveness of a short-term
psychotherapeutic intervention in outpatients engaging in NSSI.
Trial registration: The study is registered in the German Clinical Trials Register DRKS00003605.
Keywords: Non-suicidal self-injury, Self-harm, Randomized controlled trial, The Cutting-Down Programme,
Adolescents, Short-term therapyBackground
Non-suicidal self-injury (NSSI) can be defined as a self-
inflicted, deliberate, direct destruction of body tissue
without conscious suicidal intent, which is not socially
accepted [1,2]. During adolescence, prevalence ranges
between 13 and 45% worldwide [1,3,4], and studies in the
same population in Germany suggest a similar prevalence
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reproduction in any medium, provided the orconducted during 2004/2005 in the defined catchment
area (southwestern Germany), 15% of the 15-year-old
adolescents included reported NSSI in the previous six
months; 4% of them even reported repetitive NSSI [5].
Another study within the same geographical area from
2011 revealed a lifetime prevalence of any incident of
NSSI of 35% among 14- to 16-year-old adolescents [6].
NSSI is often accompanied by a variety of psychological
problems and disorders, but until recently, borderline
personality disorder (BPD) was the only disorder in the
classification systems (Diagnostic and Statistical Manual
of Mental Disorders-IV (DSM-IV) and InternationalLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Problems-10 (ICD-10) that included self-injury as a diag-
nostic criterion. NSSI can occur in the context of depres-
sive disorders, eating disorders, anxiety disorders, conduct
disorders, substance-use disorders and post-traumatic
stress disorders [7,8]. In addition, NSSI is highly associated
with suicide attempts and death by suicide in adoles-
cents [5,9]. As a result of increasing knowledge on the
phenomenon of NSSI and its growing importance, NSSI
has now been included as a section 3 disorder in the
new DSM-5 [10-12]. This fact underscores the need for
further research concerning NSSI and for the develop-
ment of specific therapeutic concepts that are empirically
validated for the condition.
To our knowledge, specific therapeutic programs focus-
ing specifically on NSSI are rare [10]. The only existing
manuals were originally developed for treatment of BPD,
and consequently treat NSSI as one symptom of this dis-
order [13,14]. In this context, the Dialectic Behavioral
Therapy for Adolescents (DBT-A) is the most common
program [15], but its effectiveness in reducing NSSI has
not been proven in a randomized controlled trial (RCT)
so far [16]. Additionally, extensive therapeutic approaches
like those for BPD may not always be adequate in light of
the high prevalence of adolescent NSSI. A new thera-
peutic approach using mentalization-based therapy
(MBT) for self-harming adolescents was recently pub-
lished by Rossouw and Fonagy. In their RCT, they were
able to achieve a recovery rate of 44% in the MBT group
compared to 17% in the group receiving treatment as
usual (TAU) [17]. However, length of treatment during
this trial was comparable to psychotherapeutic interven-
tions such as DBT-A. Treatment of NSSI is indispensable
and, therefore, there is a great need for specific and effect-
ive psychotherapeutic treatment programs for adolescent
NSSI. Such a program should focus on NSSI itself and
needs to be time and cost efficient [18]. It should aim to
reduce distress and impairment associated with negative
emotional states in young people so as to decrease subse-
quent NSSI [16].
Evans et al. [19] at Kings College London, UK, devel-
oped a short-term therapy for adults with deliberate self-
harm (DSH, which includes suicidal behavior and NSSI).
This cognitive-orientated and problem-focused short-term
therapy program, called the ‘Manual-Assisted Cognitive-
behavioural Therapy’ (MACT), consists of a maximum of
six therapeutic sessions and is assisted by a detailed man-
ual. The content of MACT involves problem finding and
solving, advantages and disadvantages of DSH, basic cog-
nitive techniques to manage emotions and negative think-
ing, finding coping strategies and relapse prevention. In a
RCT, the MACT program was tested versus TAU in 36
patients following episodes of DSH. The patients in the
TAU group were followed by psychiatrists, social workers,members of the community mental health team or no-
body. Most patients in the MACT group had therapeutic
sessions conducted by psychiatrists, nurses or social
workers, but a few of them (22.2%) only had the booklet,
which they worked through by themselves. As a result,
attempted suicide, the frequency of self-harm episodes
and the number of depressive symptoms were significantly
lower in the MACT treatment group than in the TAU
group [19].
Taylor et al. [20] adapted the MACT for adolescents
and tested it in an initial study in England. The adolescent
version of the program is called the ‘The Cutting-Down
Programme’ (CDP) and consists of 8 to 12 individual
therapy sessions. This small pilot study (n = 16), which
has recently been published [20], showed significant re-
ductions in self-harming behavior, depressive symptoms
and trait anxiety.
Objectives
The aim of the study is to determine the effectiveness of
the German CDP for treatment of NSSI in adolescents
as compared to TAU. The main outcome objective of the
trial is a clinically significant reduction (or remission)
by at least 50% in the frequency of NSSI assessed by the
Self-Injurious Thoughts and Behaviors Interview-German
(SITBI-G) [21,22]. Secondary outcome criteria are a re-
duction in symptoms of depression as measured by the
Beck Depression Inventory (BDI-II) [23] and an increase
in self-reported well-being and self-esteem as measured by
the KIDSCREEN [24] and Self-Esteem Scale (SES) [25],
respectively. Additionally, comorbid psychiatric disorders
and childhood adversity will be evaluated as predictors of
therapeutic outcome.
Primary hypothesis
Significantly more adolescents in the CDP group than in
the TAU group will experience a clinically significant re-




The trial is a single-center RCT performed at the Clinic
of Child and Adolescent Psychiatry at the University
Hospital of Heidelberg, Germany. The study protocol
was approved by the ethics committee of the medical
faculty at the University of Heidelberg. In all, 80 adoles-
cents from across the geographical area of the city of
Heidelberg between 12 and 17 years of age will be
recruited. The potential participants and their families
will be approached through our own in- and outpatient
units, official notices posted in the surgical and the
pediatric clinics, newspaper articles, advertisements on
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Figure 1 Overview of the trial procedure.
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http://www.trialsjournal.com/content/14/1/294will be initially screened via telephone to determine
eligibility and to provide detailed information about the
study.
Inclusion and exclusion criteria
Boys and girls between 12 and 17 years of age who have
engaged in at least five prior acts of cutting, burning,
stabbing, hitting, excessive rubbing, and similar injuries
during the past 6 months will be included. The last NSSI
must have occurred within the month previous to the
time of screening for the study. All adolescents are re-
quired to provide written informed consent to partici-
pate in the study, and for those under 16 years of age,
written consent also must be provided by the parents/
caregivers/legal substitute. Acute psychotic symptoms
and acute intent to harm self or others, which requires
immediate, intensive psychiatric intervention, constitute
exclusion criteria. Other exclusion critieria are impaired
intellectual functioning (according to clinical evaluation
by a psychologist, whereby only adolescents who attend a
regular school were assessed) and being in psychotherapy
at the beginning of the study or already having completed
NSSI therapy.
Procedure and randomization
After obtaining informed and written consent according
to the approved ethics committee’s protocol, an appoint-
ment for the baseline assessment will be set. The base-
line assessment will take place at the Clinic of Child and
Adolescent Psychiatry and will be performed by a clin-
ical psychologist blinded to the group affiliation. In the
baseline assessment, a broad range of psychological mea-
sures will be administered (see assessment). After eligibil-
ity is confirmed during baseline assessment, adolescents
will be enrolled in the trial and will be randomly assigned
to one of the two treatment groups as a baseline adaptive
randomization. Each participant will be informed about
the result of the randomization via telephone within seven
days after their baseline assessment. Within the following
days, the adolescents will receive a contact card, which is
adapted according to the treatment group they are allo-
cated to. Participants who are in the CDP group will
promptly receive 8 to 12 weekly individual psychotherapy
sessions. Participants in the TAU group will be referred
to the public mental health care system. A special co-
operation has been set up with the health care system to
ensure that the participants will receive the first ap-
pointment there within the following 2 to 4 weeks. After
completion of the CDP, the post-treatment assessment
will be conducted immediately, which is approximately
4 months after baseline assessment. In order to match
the assessment points between groups, TAU partici-
pants will be invited to their post-treatment assessment
4 months after the baseline. The follow-up assessmentwill take place 6 months after the post-treatment assess-
ment for every participant. The timeframe of the trial is
approximately 10 months for each of the participants,
regardless of the treatment group. Figure 1 gives an
overview of the trial procedure.
Data assessment
Semi-structured interviews and self-report question-
naires will be conducted during the three assessments in
this trial. The baseline assessment will take place before
randomization and subsequent start of treatment.
For detailed assessment of NSSI, we will use the German
version of the SITBI [22]. The SITBI-G is a semi-
structured interview to assess the presence, frequency
and characteristics of a wide range of self-injurious
thoughts and behaviors, including suicidal ideation, sui-
cide plans, suicide gestures, suicide attempts and NSSI
[21]. The SITBI-G will be repeated at the post-treatment
and follow-up assessment time points.
Furthermore, the baseline assessment comprises a
sociodemographic interview, which will gather informa-
tion about gender, date of birth, state of adolescents’ and
parents’ education and current living situation. Comorbid
diagnoses will be assessed using the German version of
the Mini-International Neuropsychiatric Interview for
children and adolescents (M.I.N.I- KID 6.0) [26] and parts
of the Structured Clinical Interview for DSM-IV-Axis II
(SCID-II) [27]. The M.I.N.I.-KID is a short, structured
diagnostic interview for DSM-IV and ICD-10 psychiatric
disorders for children and adolescents aged 6 to 17 years.
The MINI-KID follows the structure format of the adult
version of the interview. The MINI-KID is organized in
diagnostic sections, each starting with screening questions
for each disorder [26]. All questions are in a yes/no for-
mat. The SCID-II consists of a screening questionnaire
and a subsequent interview to assess axis II disorders. The
questionnaire consists of 117 screening questions for the
twelve personality disorders. In the interview only ques-
tions answered ‘yes’ require further assessment [27]. In
our trial the following parts of the SCID-II interview will
be used: avoidant, dependent, borderline and antisocial
personality disorder. Traumatic and adverse childhood
experiences will be assessed using the German version of
Table 1 Measures and time of assessment
Measure Baseline Post-treatment Follow-up




BDI-II X X X
SES X X X
KIDSCREEN X X X
ZUF-8 X X X
BDI-II Beck Depression Inventory II, CECA Childhood Experience of Care and
Abuse interview, KIDSCREEN Health Related Quality of Life Questionnaire for
Children and Young People, M.I.N.I- KID Mini-International Neuropsychiatric
Interview for children and adolescents, SES Rosenberg Self-Esteem Scale,
SCID-II Structured Clinical Interview for DSM-IV-Axis II, SITBI-G Self-Injurious
Thoughts and Behaviors Interview-German, ZUF-8 Patient Satisfaction
Questionnaire.
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interview, which is a semi-structured, retrospective inter-
view [28,29]. The CECA includes detailed assessment of
the following types of adversity: loss of a parent, parental
neglect and antipathy, physical, sexual and psychological
abuse, family arrangements, discord at home, violence
between parents, supervision and control of children, role
reversal and childhood helplessness. In addition to these
adverse experiences, the CECA contains the positive
scales: support, closeness to parents, coping and being
the parents’ favorite child [28,29]. The sociobiographic
history, the M.I.N.I-KID, the CECA and the SCID-II
interviews are parts of the baseline assessment and will
not be repeated at post-treatment or follow-up.
Three questionnaires need to be completed during the
assessment: The German version of the Beck Depression
Inventory II (BDI-II) will be used to assess the intensity
of depression according to the DSM-IV criteria. It con-
sists of 21 items. Each item is a list of four statements
arranged in increasing severity about a particular symptom
of depression. The time frame for the response is two
weeks. A value of 0 to 3 is assigned for each answer. A total
score can be summed up. A score of 0 to 13 indicates min-
imal depression, 14 to 19 indicates mild depression, 20 to
28 indicates moderate depression and a score 29 to 63 indi-
cates severe depression. A higher total score indicates more
severe depressive symptoms. The BDI-II is widely used and
is considered reliable (r = .93) and valid (r = .32-68) [23].
The KIDSCREEN questionnaire assesses adolescents’ sub-
jective health and well-being [24]. It is normed for children
and adolescent aged between 8 to 18 years. There are three
KIDSCREEN instruments available for children and adoles-
cents as well as parent/proxy versions. In our trial we will
use the KIDSCREEN-27 which consists of five Rasch-
scaled dimensions: physical well-being, psychological well-
being, autonomy and parents, peers and social support and
school environment. This version is widely used and shows
good reliability (α = .70) and validity (r = .56) [24]. The
Rosenberg Self-Esteem Scale (SES) is a 10-item self-report
measure of global self-esteem. It consists of 10 statements
related to overall feelings of self-worth or self-acceptance.
The items are answered on a four-point scale ranging from
‘strongly agree’ to ‘strongly disagree’ [25]. The BDI-II, the
KIDSCREEN and the SES questionnaires will be repeated
at the post-treatment and follow-up assessments.
The Fragebogen zur Patientenzufriedenheit (ZUF-8;
Patient Satisfaction Questionnaire) is a German ques-
tionnaire to assess treatment satisfaction of patients. It
consists of eight statements, which are answered on a
four-point scale ranging from ‘very satisfied’ to ‘quite
dissatisfied’ [30]. The ZUF will be part of the post-
treatment and the follow-up assessment.
Table 1 gives a summary of all measures used and the
corresponding time of assessment.Participants’ incentive
All participating adolescents will receive 50 Euro for
each of the three assessments.
Intervention
Each participant will be randomized to one of the two
possible treatment conditions (CDP versus TAU). At the
end of the trial it is assumed that 40 randomly selected
participants will be in each intervention condition.
Intervention one
Participants will be informed about being allocated to
the TAU group via telephone by a trained research
psychologist. During this telephone call, they will be en-
couraged to seek treatment and will be referred to the
existing mental health care system. They receive contact
details of established child psychotherapists, psychiatrists,
clinics or counseling centers. The child psychotherapists,
psychiatrists, clinics and counseling center have all been
informed about the study and have agreed to take part in
it. This collaboration was established to shorten the
waiting times (first appointment within 2 to 4 weeks) and
to guarantee rapid access to treatment for all adolescents.
In addition to the referral, each participant will receive a
contact card including the study center's telephone num-
ber and the emergency number of our clinic. This card en-
sures that all participants can contact our psychological
staff members if they have any questions or problems at
any time, and that participants receive adequate crisis
intervention if needed.
Intervention two
CDP is a manualized, short-term psychotherapy which
is designed for 8 to 12 therapeutic sessions. It includes
elements of cognitive-behavioral therapy (CBT) and
dialectic-behavioral therapy (DBT) and is specifically
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adolescents. The content of the treatment is structured
in a manual for patients and a separate manual for ther-
apists. The modules in the manual were all developed
from a comprehensive literature review on the treat-
ment of DSH including associated psychological factors
performed by the English authors who originally devel-
oped the manual [20]. The program comprises four
main modules, which can be individually expanded by
optional modules - according to requirements of the
patient. The four main modules are promoting therapy
motivation and compliance of the subjects, identifying
reasons for the existing behavior, testing alternative
behaviors instead of NSSI, and stabilizing alternative
behaviors to reduce aversive strains, which often activate
NSSI. In addition to individual therapy sessions, the
participating adolescents will be encouraged to do cer-
tain homework, which facilitates preparation and post-
processing of the therapy sessions in order to increase
their effectiveness. Like the participants in the TAU
group, the participants in the CDP will receive a contact
card so that they can contact one of our psychological
staff members if they have any questions or problems at
any time and get access to the clinic's crisis response
system.Staff
During the trial the study assessments will be performed
by a clinical psychologist. It is important to note that
data collection and psychotherapy are strictly separated
in this trial. The assessments will always be performed
by the same clinical psychologist, who is blinded to the
randomization and the respective treatment group. The
psychotherapists giving treatments are kept unaware of
the results of the psychometric assessments.Training and support of the staff members
All treating psychotherapists in the CDP will be super-
vised on a monthly basis by a specifically trained super-
visor (with a clinical background in CBT and DBT) who
will ensure quality and adherence to the treatment
manual. To guarantee good adherence, the therapist
documents all sessions in according protocols and, if
the participants have agreed, records the session. The
protocols are checked every week. In emergency situa-
tions, all clients have unlimited access to the on-call
system of the Clinic of Child and Adolescent Psychiatry.Sample size
With an expected response rate of 25% in TAU and 60%
in CDP, a sample size of 40 for each group is needed to
achieve sufficient power (85%).Statistical analysis
To ensure objectivity of the data collection setting the
whole process has been standardized. Data collection and
treatment will be strictly separated and performed by dif-
ferent personnel (blinded). The data collection process
comprises the baseline, the post-treatment and the follow-
up assessment. All analyses will be intent-to-treat analyses.
If post-treatment or follow-up assessments are missing,
the missing assessment will be filled with the last non-
missing value. NSSI, which is the main outcome of this
trial, will be assessed using the SITBI-G. A clinically
significant improvement is defined as a reduction in the
frequency of NSSI by 50%. In this process the TAU group
and the CDP group will be compared with each other to
determine any differences in primary and secondary out-
comes by using a χ2 - test. As a secondary measure,
ANCOVA with group as factor and frequency of NSSI at
baseline as covariate will be assessed. Explorative analysis
will be executed to account for the influence of childhood
trauma, psychiatric diagnosis and personality traits and
other factors potentially influencing the patients (for
example, gender). Descriptive analysis will be used to
characterize the study sample. For nominal data fre-
quencies will be determined, and for continuous data
means and standard deviations with confidence inter-
vals will be calculated. A significance level of α = .05 will
be chosen. Statistical analysis will be performed using
Stata 13.Ethical issues
The study will be performed in accordance with the
Declaration of Helsinki. Approval for the study was
obtained from the ethics commission of the Faculty of
Medicine at the University of Heidelberg (Ethics Com-
mittee No.: S-363/2011). Only those who have provided
written informed consent will be included in the trial. If
the participants are younger than 16, caregivers’ written
consent must be provided as well. Each potential partici-
pant and his/her family will be contacted by telephone
and provided with a copy of the information sheets, which
include a contact number, so that they have the opportun-
ity to ask questions.Discussion
This present study in adolescents with NSSI is the first
RCT worldwide that uses the CDP. We are testing the
brief therapeutic intervention program to help adolescents
who show repetitive NSSI, some of whom have not re-
ceived any treatment for years. The aim of this treatment
program is to end, or at least significantly reduce NSSI.
The use of a short-term psychotherapeutic intervention
may have many more benefits for these adolescents and
their families. For example, adolescents may learn how to
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stressful everyday life, especially with regard to family life.
The potential benefit of the ‘The Cutting-Down
Programme’ has recently been shown in the study pub-
lished by Taylor et al. [20]. This study found significant
reductions in self-harming behavior, depression symp-
toms and trait anxiety; however, no control group was
used to account for non-specific study effects [20].
In Germany this is the first trial to test a short-term
therapy in adolescents engaging in NSSI. It is very im-
portant to note that this short-term therapy constitutes
a very specific approach with a low threshold because of
its short time frame. That should help to increase motiv-
ation to access therapy and decrease the fear of being
stigmatized or stigmatizing themselves.
To the best of our knowledge, no other such specific
treatment for treating young people with NSSI exists
worldwide, although prevalence of NSSI is high and has
continued to rise within the last year [31]. Most of the ap-
proaches for treating NSSI are part of the DBT-A pro-
gram, which has been primarily designed for patients with
BPD and for which evidence for use in adolescents is lack-
ing. However, treating all adolescents engaging in NSSI
with a BPD-specific program may not be the best ap-
proach, considering financial resources available in many
public mental health systems. It is known that the existing
programs do not always stop or reduce NSSI. Moreover,
many of the adolescents engaging in NSSI do not fulfill
the criteria of any psychiatric diagnosis [31]; therefore, a
specific program and diagnosis is needed for NSSI itself.
In our opinion this new approach may be a better way to
encourage young people with NSSI to get necessary and
specific treatment, which may be sufficient for termination
of NSSI within a short period of time. We propose that
the program is very effective in terms of reducing or ter-
minating NSSI and it will not involve high economic costs,
especially because it is a short-term program.
Limitations
The Heidelberg region is a particularly wealthy part of
Germany, which may have the effect that our findings can-
not be generalized to more rural or socioeconomically
poorer areas. However, we aim to include every interested
adolescent who fits the inclusion criteria without any re-
gard for background (for example, adolescents who live in
assisted living, a children’s home or a more rural region
around Heidelberg).
If the program proves to be clinically effective, it can
be delivered widely across psychologists, psychiatrists
and therapists who deal with NSSI in adolescents.
Trial status
Baseline assessments and subsequent intervention started
in November 2012 and so far 22 participants have beenrandomized. The entire trial is scheduled to be completed
by the end of 2014.
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